Pharma partnering

Roche is dedicated to finding and building partnerships. Together with partners, Roche aims to bring new medicines to patients as quickly as possible. Partnering is the doorway to every part of the Roche organisation – from scientists to life cycle teams to the highest levels of management.

Roche Pharma Partnering team is dedicated to finding the best advances in modern medicine that strengthen the R&D portfolio.

With around 80 people, Pharma Partnering is like a small biotech company. This enables Roche to offer speed, flexibility, accessibility and decision making authority. Roche’s team is highly qualified and covers a diversity of roles: finders, analysts, negotiators, lawyers, due diligence managers, alliance management specialists, information specialists, and communications experts. Pharma Partnering has offices in Basel (Swizerland), Nutley (USA), South San Francisco (USA), Welwyn (UK), and Shanghai (China).

Roche looks forward to the challenge of transforming key partnerships into long-term strategic alliances. Success is much more than the deal itself. Real rewards come through partnerships that work in the long run.

Roche offers creative deal structures tailored to the needs and ambitions of its partners. Roche’s teams always put the interests of the product first. And for partners, Roche offers a seat at the table when it comes to important development decisions.

Roche searches for partners based on both strategic and cultural fits. We look for product opportunities in our five Disease Biology Areas of oncology, metabolism, CNS, inflammation and virology.

In research and technologies, we actively pursue opportunities in medicinal chemistry, synthesis and screening, combinatorial chemistry, molecular modeling, genetics, genomics, proteomics and RNAi technology.

We always look for partners that have a shared vision,  strong motivation and an ambitious outlook. Flexibility is important, as is solid management and a capacity for long-term growth. Of course, like our own R&D, creative ideas and scientific rigour are paramount.